# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Barclays analyst Manav Patnaik maintains Clarivate (NYSE:CLVT) with a Underweight and lowers the price target from $6 to $5.
RBC Capital analyst Ashish Sabadra maintains Clarivate (NYSE:CLVT) with a Sector Perform and lowers the price target from $8...
Jonathan Gear, Chief Executive Officer, will step down as CEO and as a member of the Board at that time, and will transition i...
"We continue to expect our full year 2024 financial results to be in the range of our existing outlook," said Jonathan ...
Clarivate (NYSE:CLVT) reported quarterly earnings of $0.20 per share which beat the analyst consensus estimate of $0.18 by 11.1...
Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, today announced the launch of the new OFF-...
Rowan TELS Corp. is the provider of Rowan Patents – an integrated patent drafting and prosecution solution specially designed f...
Top mid-cap stock performers: VIRT (+30%), VFC (+22%), NFE (+20%), RIOT (+16%), CLVT (+14%), AMN (+14%), BKU (+13%), MARA (+12%...